Northern Trust Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $279,028 - $293,158	-1,925 Reduced 0.33%	572,845 $86.6 Million
Q2 2022 Aug 12, 2022	BUY	$83.14 - $145.99 $4.01 Million - $7.04 Million	48,218 Added 9.16%	574,770 $83.7 Million
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $6.05 Million - $7.85 Million	-54,922 Reduced 9.45%	526,552 $62.4 Million
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $2.52 Million - $3.75 Million	25,281 Added 4.55%	581,474 $80.1 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $362,977 - $510,077	-3,672 Reduced 0.66%	556,193 $77.3 Million
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $1.27 Million - $2.03 Million	19,323 Added 3.57%	559,865 $54.4 Million
Q1 2021 May 12, 2021	SELL	$64.07 - $91.75 $1.18 Million - $1.69 Million	-18,432 Reduced 3.3%	540,542 $36.9 Million
Q4 2020 Feb 11, 2021	SELL	$65.07 - $98.24 $790,275 - $1.19 Million	-12,145 Reduced 2.13%	558,974 $47.9 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $914,942 - $1.21 Million	-15,497 Reduced 2.64%	571,119 $37.1 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $1.79 Million - $4.59 Million	61,824 Added 11.78%	586,616 $42.9 Million
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $1.37 Million - $2.86 Million	49,949 Added 10.52%	524,792 $17.9 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $613,145 - $865,095	-15,006 Reduced 3.06%	474,843 $25.9 Million
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $3.41 Million - $4.51 Million	91,128 Added 22.86%	489,849 $20.4 Million
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $541,661 - $912,207	13,613 Added 3.53%	398,721 $17.5 Million
Q1 2019 May 13, 2019	BUY	$34.52 - $53.29 $1.36 Million - $2.1 Million	39,475 Added 11.42%	385,108 $19.8 Million
Q4 2018 Feb 12, 2019	SELL	$29.75 - $42.9 $18,921 - $27,284	-636 Reduced 0.18%	345,633 $12.8 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $732,725 - $960,878	22,346 Added 6.9%	346,269 $13 Million
Q2 2018 Sep 18, 2018	SELL	$23.62 - $42.29 $57,113 - $102,257	-2,418 Reduced 0.74%	323,923 $12.8 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $531,709 - $951,990	22,511 Added 7.41%	326,341 $12.9 Million
Q1 2018 May 09, 2018	BUY	$22.49 - $34.56 $4.19 Million - $6.44 Million	186,274 Added 158.46%	303,830 $7.83 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $3,025 - $5,262	148 Added 0.13%	117,556 $3.17 Million
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $2.76 Million - $4.49 Million	117,408	117,408 $4.39 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account